Ambu A/S (AMBFF) Stock Analysis & Winston Score
Ambu is a Danish medical device company that makes single-use endoscopes and patient monitoring equipment. Endoscopes are small cameras doctors insert into the body to see inside airways, bladders, and other areas. Ambu pioneered the idea of disposable endoscopes, replacing traditional reusable ones that require expensive cleaning between patients. The company earns revenue by selling its single-use devices to hospitals and clinics, creating a recurring demand since each device is thrown away after one procedure. Ambu operates globally, with major markets in North America and Europe, and has a market cap of around $2.7 billion. Its competitive moat comes from being the first mover in single-use endoscopy, holding key patents and strong brand recognition among healthcare providers. The main growth driver is expanding into new endoscope categories beyond its core pulmonary line, though the company faces ongoing pressure to prove that disposable devices can match reusable ones on both cost and clinical performance.
Winston Score: 61/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (17/30)
- Growth: Good (10/20)
- Cash Flow: Strong (8/10)
- Stability: Exceptional (9/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)
Key Facts
Price: $10.10
Market Cap: $2.7B
Sector: Healthcare
Industry: Medical - Devices
Exchange: Other OTC


